SRI International

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1946-11-06

Employees: 1K

Market Cap: -

Website: http://www.sri.com

Clinical Trials

Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System

Terminated

Conditions: Anthrax

Interventions: Diagnostic Test: Anthrax LF Dx System

First Posted Date: 2023-01-05

Last Posted Date: 2023-11-30

Lead Sponsor: SRI International

Target Recruit Count: 343

Registration Number: NCT05672875

Locations: 🇺🇸
WellNow Urgent Care and Research, Dayton, Ohio, United States

Study of Single Oral Doses of HOPO 14-1 Evaluating Safety, Tolerability, Pharmacokinetics

Phase 1

Recruiting

Conditions: Toxicity;Chemical

Interventions: Drug: HOPO 14-1

First Posted Date: 2022-11-29

Last Posted Date: 2023-05-24

Lead Sponsor: SRI International

Target Recruit Count: 42

Registration Number: NCT05628961

Locations: 🇺🇸
SRI Biosciences Clinical Trials Unit, Plymouth, Michigan, United States

Sleep and Emotional Reactivity in Alcohol Use Disorder

Not Applicable

Conditions: Alcohol Use Disorder (AUD)

Interventions: Other: Uninterrupted sleep followed by functional neuroimaging.

First Posted Date: 2021-07-28

Last Posted Date: 2021-07-28

Lead Sponsor: SRI International

Target Recruit Count: 100

Registration Number: NCT04979507

Locations: 🇺🇸
SRI International, Menlo Park, California, United States

Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine

Phase 1

Conditions: Encephalomyelitis
Brain Diseases
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Togaviridae Infections
Encephalitis
Encephalitis, Viral
Infectious Encephalitis
Virus Diseases

Interventions: Biological: Vaccinations on Day 0, Day 28, and Day 140

First Posted Date: 2018-12-17

Last Posted Date: 2021-02-23

Lead Sponsor: SRI International

Target Recruit Count: 48

Registration Number: NCT03776994

Locations: 🇺🇸
SRI Biosciences Clinical Trials Unit, Plymouth, Michigan, United States

Sleep and Cardiovascular Health in Adolescence

Not Applicable

Completed

Conditions: Insomnia Type; Sleep Disorder

Interventions: Other: No pre-sleep arousal manipulation
Other: pre-sleep arousal down-regulation
Other: pre-sleep arousal up-regulation

First Posted Date: 2018-11-01

Last Posted Date: 2023-05-01

Lead Sponsor: SRI International

Target Recruit Count: 115

Registration Number: NCT03727906

Locations: 🇺🇸
SRI International, Menlo Park, California, United States

Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging

Not Applicable

Withdrawn

Conditions: Skin Manifestations

Interventions: Drug: TDS Lidocaine 5%; generic
Drug: TDS Lidocaine 5%; RLD

First Posted Date: 2016-06-01

Last Posted Date: 2017-10-09

Lead Sponsor: SRI International

Registration Number: NCT02787356

Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking

Not Applicable

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2006-03-10

Last Posted Date: 2013-12-19

Lead Sponsor: SRI International

Target Recruit Count: 1200

Registration Number: NCT00301145

Locations: 🇺🇸
SRI International, Menlo Park, California, United States
🇺🇸
Center for Health Studies, Seattle, Washington, United States
🇺🇸
Free & Clear, Incorporated, Seattle, Washington, United States

Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: TAS-108

First Posted Date: 2005-09-14

Last Posted Date: 2015-08-18

Lead Sponsor: SRI International

Target Recruit Count: 146

Registration Number: NCT00166543

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy